Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravenous iron sucrose in elderly patients hospitalized with heart failure and iron deficiency
ChiCTR2100049128Phase 4Completed
- Sponsor
- Qingdao Municipal Hospital Group
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of iron sucrose in heart failure (HF) and iron deficiency anemia (IDA) (2 arms), sponsored by Qingdao Municipal Hospital Group. Primary endpoint: Composite of total heart failure hospitalizations and cardiovascular death. Started Jan 2018; status: completed.
02
Drugs
iron sucrose
03
Conditions
heart failure (HF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2100049128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049128.